EGFR and squamous cell carcinoma: In this study, although the rate of EGFR-TKIs sensitive mutation in squamous cell carcinoma and adenosquamous carcinoma was obviously lower than with adenocarcinoma, but it is clear that the rate is higher than other geographical regions [27].